SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : World Heart Corp - WHRT and TSE/WHT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Hamilton who wrote (70)4/4/1998 5:31:00 PM
From: Dan Hamilton  Read Replies (1) of 500
 
I don't know if I'm the onnnnllly one left on this thread, but here's some more information. There was a recent article on World Heart in the Ottawa Business Journal, and it quotes Jean-Luc Berger, a biotech analyst with Toronto based CrediFinance Securities. He has a buy recommendation on the stock. He says it appears WorldHeart has a two year lead on their closest competitor Abiomed and he likes their strong management team.

He says if they capture 20% of the market, it would translate into $3 billion per year in sales.

Pre-clinical trials are beginning this year at the Ottawa Heart Institute and clinical trials begin in 1999 at the Cleveland Clinic and other facilities in the United States and Europe.

10 years and $40 million in R&D to date. It's all coming together...

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext